Combining mucosal microbiome and host multi-omics data shows prognostic potential in paediatric ulcerative colitis
Open Access
- 4 August 2025
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 7157
Abstract
Current first-line treatments of paediatric ulcerative colitis (UC) maintain a 6-month remission in only half of the patients. Relapse prediction at diagnosis could enable earlier introduction of immunosuppressants. We collected intestinal biopsies from 56 treatment-naïve children, combining mucosal quantitative microbial profiling with host epigenomics, transcriptomics, genotyping, and in vitro and in vivo experiments on selected bacteria. Baseline bacterial diversity is lower in relapsing children, who have fewer butyrate producers but more oral-associated bacteria, whereof Veillonella parvula induces inflammation in epithelial cell lines and IL10-/- mice. Microbiota has the strongest association with future relapse, followed by host epigenome and transcriptome. Interferon gamma signalling is also linked to relapse-associated bacteria. Relapse-prediction using separate omics data is outperformed by a robust machine learning approach combining microbiomes and epigenomes. In summary, host-microbe data have prognostic potential in paediatric UC. Our translational findings also suggest that pro-inflammatory oral-associated colonizers can exploit the reduced colonic bacterial diversity of relapsing children.Keywords
This publication has 127 references indexed in Scilit:
- Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter StudyGastroenterology, 2007
- Interferon-gamma is causatively involved in experimental inflammatory bowel disease in miceClinical and Experimental Immunology, 2006
- Adjusting batch effects in microarray expression data using empirical Bayes methodsBiostatistics, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Intercellular adhesion molecule-1 (ICAM-1) in ulcerative colitis: Presence, visualization, and significanceInflammation Research, 2005
- Interferon-β-1a for the Treatment of Steroid-Refractory Ulcerative Colitis: A Randomized, Double-Blind, Placebo-Controlled TrialClinical Gastroenterology and Hepatology, 2005
- Toll-like receptor 9–induced type I IFN protects mice from experimental colitisJournal of Clinical Investigation, 2005
- Interferon-γ and Tumor Necrosis Factor-α Synergize to Induce Intestinal Epithelial Barrier Dysfunction by Up-Regulating Myosin Light Chain Kinase ExpressionThe American Journal of Pathology, 2005
- Inhibition of IFN-γ Signaling by GlucocorticoidsThe Journal of Immunology, 2003
- IMPROVED MEDIUM FOR SELECTIVE ISOLATION OF VEILLONELLAJournal of Bacteriology, 1958